Comparison of the Effect of Rabeprazole 50 mg DDR Capsules and 20 mg Enteric-coated Tablets

NCT03037606 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastroesophageal Reflux Disease

Interventions

DRUG: Rabelis DDR 50 mg Capsules
DRUG: Pariet 20 mg Enteric Coated Tablets

Sponsor

Neutec Ar-Ge San ve Tic A.Ş